Meeting on the Mesa 2026 has ended. This guide stays up as the record of who was there. Next: Meeting on the Mesa 2027, Oct 18–20, 2027 in Phoenix

Gene editing at Meeting on the Mesa 2026

Oct 5–7, 2026 Phoenix, AZ ~1.5k attendees Website

30 organizations at Meeting on the Mesa 2026 present work in gene editing: 21 therapy developers, 8 suppliers and service providers and 1 academic or public organization. Between them they bring 17 presentations to the program. Most represented: Arbor Biotechnologies (1 on the program), ElevateBio (1 on the program), BlueRock Therapeutics (1 on the program). As of Oct 6, 2026.

All 592 organizations at Meeting on the Mesa 2026 →

Format
Top represented
Showing 1–19 of 30 organizations
OrganizationMeeting on the Mesa 2026 Attendance
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops gene-editing therapeutics for genetic diseases, including liver and central nervous system conditions and rare disorders.
ElevateBio
Waltham, MA
◆Diamond Sponsor
CDMO & CRODiamond Sponsor
Provides gene-editing technologies, discovery services, and cGMP development and manufacturing for advanced therapy companies from early research through commercialization.
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops engineered cell therapies using pluripotent stem cells and genome editing for neurological, cardiac, and immune diseases.
Editas Medicine
Cambridge, MA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops CRISPR-based gene-editing medicines for genetic diseases.
Panel
Tue, Oct 6
11:15am
Platform Technologies Across Modalities
Applied StemCell
Milpitas, CA
◇Silver Sponsor
◇Partnering Sponsor
Tools & equipmentSilver Sponsor
Provides CRISPR genome-editing reagents, engineered cell lines, and custom gene-editing services for research and cell therapy development.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Beam Therapeutics
Cambridge, MA
◇Silver Sponsor
Cell & gene therapySilver Sponsor
Develops base-editing medicines that precisely modify genes to treat serious diseases.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Pluristyx
Seattle, WA
Tools & equipment
Provides research and clinical-grade iPSC products, gene-editing technologies, cell differentiation, and development services for cell therapy developers.
Panel
Mon, Oct 5
5:00pm
Cell & gene therapy
Develops RNA exon-editing therapies that restore full-length proteins for retinal, neurological, neuromuscular, renal, and genetically defined diseases.
Spotlight
Mon, Oct 5
4:30pm
Innovation Spotlight company presentation
Cell & gene therapy
Develops genome-editing technologies and therapeutic programs for genetic diseases, including engineered editing systems designed for precision and delivery.
Spotlight
Mon, Oct 5
11:45am
NTrans Technologies
Leiden, Netherlands
Cell & gene therapy
Develops nonviral intracellular delivery technology for CRISPR, base and prime editing, including therapies for genetic diseases.
Cell & gene therapy
Develops in vivo gene-editing therapies using its ARCUS platform for infectious and rare diseases.
Spotlight
Mon, Oct 5
11:30am
Innovation Spotlight company presentation
RheumaGen
Aurora, CO
Cell & gene therapy
Develops HLA gene-editing therapies intended to treat rheumatoid arthritis, multiple sclerosis, and other autoimmune diseases.
Cell & gene therapy
Develops CRISPR-based in vivo genetic medicines, including liver-targeted therapies designed to epigenetically silence disease-related genes.
Spotlight
Mon, Oct 5
5:15pm
Cell & gene therapy
Develops Dualase genome-editing therapies delivered by AAV or RNA, initially targeting DNA repeat expansion disorders including inherited ALS.
Cell & gene therapy
Develops CRISPR-based gene-editing therapies for serious diseases, including in vivo and engineered-cell treatment programs.
Panel
Tue, Oct 6
9:30am
Prime Medicine
Cambridge, MA
Cell & gene therapy
Develops gene therapies using Prime Editing to precisely correct disease-causing mutations.
Cartherics
Melbourne, Australia
Cell & gene therapy
Develops off-the-shelf immune cell therapies using gene-edited cells for ovarian cancer, endometriosis and other diseases.
Attending
On the meeting’s published attendee list
GenScript
Nanjing, China
CDMO & CRO
Provides gene synthesis, genome-editing, plasmid, viral-vector, cell-therapy and biologics development and manufacturing services, plus research reagents.
Attending
On the meeting’s published attendee list
Helex
Cambridge, MA
Cell & gene therapy
Develops gene-editing medicines using lipid nanoparticles to treat genetic kidney diseases.
Attending
On the meeting’s published attendee list

Explore the full Meeting on the Mesa 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full Meeting on the Mesa 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in gene editing

Tell us what you sell and we’ll find the people at organizations working on gene editing most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse Meeting on the Mesa 2026 by

Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction